You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
粵澳初步共識接種至少1劑疫苗者可延長核檢有效期
澳門新型冠狀病毒感染應變協調中心於昨日舉行記者會,就記者問及粵港澳通關便利措施問題,澳門仁伯爵綜合醫院醫務主任戴華浩表示,廣州疫情漸趨緩和,粵澳兩地已開展討論是否可延長已接種疫苗人士的核酸檢測有效期,並已達成初步共識,對已接種至少1劑疫苗的通關人士,他們持有的核酸檢測報告有效期可適當延長,無接種疫苗者亦可通關,但肯定接種疫苗的人通關更便利。

他亦強調雙方仍需在技術層面上磋商,具體落實時間會適時公布。此外,粵澳兩地正商討疫苗資料庫,期望日後可在健康碼上對接和資料庫互用。至於與香港通關方面,他重申,目前雙方仍在細節性討論有關方案,暫沒有具體時間表,有方案時會適時公布。(wl/k)

~

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account